TP53INP2 and renal cell carcinoma: lncRNA IGFL2-AS1 increases tumor protein TP53INP2 (tumor protein p53 inducible nuclear protein 2) mRNA levels in sunitinib-resistant RCC cells by competitively binding to HNRNPC (heterogeneous nuclear ribonucleoprotein C).